← Back to patent-cliff list
CAS 38025-45-5
1-Benzyl-4-phenyl-1,2,3,6-tetrahydropyridine
Codes: (IV)663167-2-a
Application context (from source-drug indications)
Biliary tract cancerTasurgratinibBile duct cancerTasurgratinibSolid tumourTasurgratinibCholangiocarcinomaTasurgratinibBreast cancerTasurgratinibHepatic function declineTasurgratinib
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Tasurgratinib | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
1-(Phenylmethyl)-4-piperidinone→Bromo(phenyl)magnesium→1-Benzyl-4-phenylpiperidin-4-ol→1-Benzyl-4-phenyl-1,2,3,6-tetrahydropyridine→4-Phenylpiperidine
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.